GlassScriptPhysician profile
Matthew T Gall
NPI 1457320509
$35,790.06
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $29,260.87 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $5,940.11 | 2019 | |
| Incyte Corporation | $108.87 | 2019 | |
| Astellas Pharma US INC | $106.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $81.99 | 2019 | |
| Genentech USA, INC. | $33.04 | 2019 | |
| Pfizer INC. | $31.17 | 2019 | |
| Tersera Therapeutics LLC | $28.88 | 2019 | |
| Gilead Sciences, INC. | $28.01 | 2019 | |
| Lilly USA, LLC | $25.76 | 2019 | |
| Taiho Oncology, INC. | $20.38 | 2019 | |
| Novocure INC. | $19.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.87 | 2019 | |
| Secura Bio, INC. | $16.66 | 2019 | |
| Janssen Biotech, INC. | $15.75 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agios Pharmaceuticals, INC. | $15.23 | 2019 | |
| Daiichi Sankyo INC. | $15.02 | 2019 | |
| Amgen INC. | $13.39 | 2019 | |
| Exelixis INC. | $11.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Gall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.